Patent ID: 11945930
Assignee: PARIS SCIENCES ET LETTRES
Field: Other special machines (Mechanical engineering)
Classification: CPC C | IPC C

Claim 8:
9. The process according to claim 1, wherein the liquid phase further comprises:
nanoparticles, chosen from the group of:
metal oxide nanoparticles, or titanium dioxide (TiO2) or aluminum oxide (Al2O3) nanoparticles,
metallic nanoparticles, or silver (Ag), gold (Au), iron (Fe), nickel (Ni), copper (Cu)
or

germanium (Ge) nanoparticles,
bi-metallic nanoparticles, or gallium arsenide (GaAs), lead telluride (PbTe), or iron platinum (FePt) nanoparticles,
tri-metallic nanoparticles, or aluminum gallium arsenide (AlxGa1-xAs) nanoparticles,
ceramic nanoparticles, or silicon carbide (SiC) or tungsten carbide (WC) nanoparticles,
magnetic nanoparticles, or iron oxide (Fe2O3) nanoparticles,
silica (SiO2) nanoparticles,
polymeric nanoparticles,

or mixtures thereof,, or
an active pharmaceutical ingredient, chosen from the group of:
anti-inflammatory drugs, or diclofenac, ibuprofen, acetyl salicylic acid, or steroid based anti-inflammatory drugs,
anti-cancer drugs, or paclitaxel, docetaxel, or doxorubicin,
analgesics, or morphine,
antibiotics, or penicillin or sulfonamide antibiotics,

said active pharmaceutical ingredient optionally comprising a radiotracer,, or
a contrast agent or ipodate sodium,, or
a dye, or an organic dye, or a water soluble organic dye, pigments, or quantum dots, or a dye chosen from the group consisting of:
Fluorescein, Eosin, Amaranth, Sanolin Blue NBL, Anthocyanins, methylene blue, indocyanine green (ICG), Rhodamine B, Cyanine, Evans Blue, Primulin, Isamine Blue, and Naphtol green B,, said nanoparticles, active pharmaceutical ingredient, contrast agent or dye being optionally coupled to a fluorophore.